Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2 BCR-ABL1 transcript with a somatic mutation in TP53BP2 and cadherin-10 genes-MedSci.cn

Molecular characterization and therapeutic reaction to dasatinib in a CML patient harboring a novel e8a2 BCR-ABL1 transcript with a somatic mutation in TP53BP2 and cadherin-10 genes

Zhang, Y; Cheng, Z; Yan, WZ; Liu, SF; Hu, CH; Zhang, GS

Zhang, GS (reprint author), Cent S Univ, Xiang Ya Hosp 2, Inst Mol Hematol, Dept Hematol, Changsha 410011, Hunan, Peoples R China.